Revenue
2022
2023
2024
2025
SPRUCE BIOSCIENCES, INC. (SPRB)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2019
2020
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $4.9M | $10.1M | $0 | — | — | — |
| Research & development | $19.5M | $46.4M | $49.4M | $35.2M | $30.7M | $23.9M | $10.8M |
| Operating expenses | $36.5M | $61.1M | $62.1M | $47.3M | $42.1M | $29.4M | $13.1M |
| Operating income | −$36.5M | −$56.2M | −$52.0M | −$47.3M | −$42.1M | −$29.4M | −$13.1M |
| EBITDAderived | −$36.5M | −$56.1M | −$51.9M | −$47.2M | −$42.0M | −$29.4M | −$13.1M |
| Net income | −$39.0M | −$53.0M | −$47.9M | −$46.2M | −$42.3M | −$29.5M | −$13.1M |
| Basic EPSper diluted share | -$50.83 | -$96.40 | -$1.24 | -$1.96 | -$1.81 | -$4.93 | -$17.12 |
| Diluted EPSper diluted share | -$50.83 | -$96.40 | -$1.24 | -$1.96 | -$1.81 | -$4.93 | -$17.12 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Oct 6, 2025Form 4 | Parkman Healthcare Partners LLC +1TenPercentOwner | SellCommon Stock, $0.001 par value per share · indirect | 25 | $17.46 | $436.50 | 1.1K |
| Oct 6, 2025Form 4 | Parkman Healthcare Partners LLC +1TenPercentOwner | SellCommon Stock, $0.001 par value per share · indirect | 232 | $19.33 | $4.5K | 1.1K |
| Oct 6, 2025Form 4 | Parkman Healthcare Partners LLC +1TenPercentOwner | BuyCommon Stock, $0.001 par value per share · indirect | 256 | $17.91 | $4.6K | 1.3K |
| Oct 6, 2025Form 4 | Parkman Healthcare Partners LLCTenPercentOwner | SellCommon Stock, $0.001 par value per share · indirect | 25 | $17.46 | $436.50 | 1.1K |
| Oct 6, 2025Form 4 | Parkman Healthcare Partners LLCTenPercentOwner | SellCommon Stock, $0.001 par value per share · indirect | 232 | $19.33 | $4.5K | 1.1K |